论文部分内容阅读
１９８３─１９９３年６月收治肢端肥大症２８例中，糖耐量异常（ＩＧＴ）５例占１８．５％，糖尿病１１例占３９．２８％，采用溴隐亭治疗５例ＩＧＴ恢复正常，３例无临床症状，ＦＢＳ８．８～１５ｍｍｏｌ／Ｌ治疗一月后ＦＢＳ降至正常。４例有临床症状ＦＢＳ１５～１６ｍｍｏｌ／Ｌ，仅用溴隐亭７．５～１５ｍｇ／日治疗，ＦＢＳ除１例外均正常。４例ＦＢＳ１２．０４６～４９．２３７ｍｍｏｌ／Ｌ，尿糖＋＋～＋＋＋，采用饮食控制并加用胰岛素２４～９６ｕ／日，３例再加服优降糖２．５～７．５ｍｇ／日，疗效不佳，加用溴隐亭后获得较明显效果。认为肢端肥大症继发糖尿病，采用治疗Ⅰ型、Ⅱ型糖尿病的方法，均不能获得满意疗效，即使放疗后或手术加放疗后均一样，应首选溴隐亭治疗。
Among the 28 cases of acromegaly admitted from 1983 to June 1993, IGT was found in 5 cases (18.5%) and diabetes mellitus (11 cases) in 39.28% cases. Five cases of bromocriptine treatment returned to normal, 3 Cases without clinical symptoms, FBS8.8 ~ 15mmol / L treatment of January after the FBS dropped to normal. 4 cases of clinical symptoms FBS15 ~ 16mmol / L, only bromocriptine 7.5 ~ 15mg / day treatment, FBS except 1 case were normal. 4 cases of FBS12.046 ~ 49.237mmol / L, urine sugar ++ ~ +++, using diet control plus insulin 24 ~ 96u / day, 3 cases plus plus hypoglycemic 2.5 ~ 7.5mg / day, efficacy Poor, plus bromocriptine after more obvious results. Acromegaly secondary diabetes that the use of treatment of type â ... ¡, type â ... ¡diabetes, are not able to obtain satisfactory results, even after radiotherapy or surgery plus radiotherapy are the same, should be the preferred bromocriptine treatment.